Literature DB >> 9117180

Prevalence of hip problems in the population aged 55 years and over: access to specialist care and future demand for hip arthroplasty.

J Fear1, M Hillman, M A Chamberlain, A Tennant.   

Abstract

To determine the prevalence of hip problems in the population aged 55+, a postal questionnaire was sent to a multistage stratified random sample of residents of a health district with an over-55 population of 210,000. An initial four page postal questionnaire produced an 86% response rate from 18,827 eligible cases. A subsequent detailed questionnaire (with a response rate of 78%) then determined the prevalence of severe pain and severe disability amongst those with hip problems. The prevalence of those with existing hip replacements is estimated at 32.1/1000 (95% CI 29.5-34.9). An estimated 13.5/1000 (95% CI 12.4-14.7/1000) displayed levels of pain and disability consistent with a current need to consider arthroplasty. In addition, it appears that the over 75s are less likely to have access to appropriate surgery. Unless health authorities and, increasingly, general practitioners consider purchasing more hip replacements, the prevalence pool of those who could benefit will inexorably rise.

Entities:  

Mesh:

Year:  1997        PMID: 9117180     DOI: 10.1093/rheumatology/36.1.74

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  11 in total

1.  Health impact of pain in the hip region with and without radiographic evidence of osteoarthritis: a study of new attenders to primary care. The PCR Hip Study Group.

Authors:  F Birrell; P Croft; C Cooper; G Hosie; G Macfarlane; A Silman
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

2.  Health-related quality of life in patients with hip or knee osteoarthritis: comparison of generic and disease-specific instruments.

Authors:  Fausto Salaffi; Marina Carotti; Walter Grassi
Journal:  Clin Rheumatol       Date:  2004-07-17       Impact factor: 2.980

3.  Back pain and total hip arthroplasty: a prospective natural history study.

Authors:  Javad Parvizi; Aidin E Pour; Alan Hillibrand; Grigory Goldberg; Peter F Sharkey; Richard H Rothman
Journal:  Clin Orthop Relat Res       Date:  2010-02-03       Impact factor: 4.176

4.  Predictors of patient relevant outcome after total hip replacement for osteoarthritis: a prospective study.

Authors:  A-K Nilsdotter; I F Petersson; E M Roos; L S Lohmander
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

5.  Equity in access to total joint replacement of the hip and knee in England: cross sectional study.

Authors:  Andy Judge; Nicky J Welton; Jat Sandhu; Yoav Ben-Shlomo
Journal:  BMJ       Date:  2010-08-11

6.  Quality of life and functionality after total hip arthroplasty: a long-term follow-up study.

Authors:  Massimo Mariconda; Olimpio Galasso; Giovan Giuseppe Costa; Pasquale Recano; Simone Cerbasi
Journal:  BMC Musculoskelet Disord       Date:  2011-10-06       Impact factor: 2.362

7.  Prevalence of hip pathology in patients over age 50 with spinal conditions requiring surgery.

Authors:  Byung Ho Lee; Seong Hwan Moon; Hwan Mo Lee; Tae Hwan Kim; Seung Ju Lee
Journal:  Indian J Orthop       Date:  2012-05       Impact factor: 1.251

Review 8.  Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports.

Authors:  R Andrew Moore; Sheena Derry; Geoffrey T Makinson; Henry J McQuay
Journal:  Arthritis Res Ther       Date:  2005-03-24       Impact factor: 5.156

Review 9.  Determinants of demand for total hip and knee arthroplasty: a systematic literature review.

Authors:  Rubén E Mújica Mota; Rosanna Tarricone; Oriana Ciani; John F P Bridges; Mike Drummond
Journal:  BMC Health Serv Res       Date:  2012-07-30       Impact factor: 2.655

10.  Validation of a screening questionnaire for hip and knee osteoarthritis in old people.

Authors:  José M Quintana; Inmaculada Arostegui; Antonio Escobar; Iratxe Lafuente; Juan C Arenaza; Isidoro Garcia; Urko Aguirre
Journal:  BMC Musculoskelet Disord       Date:  2007-08-23       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.